1. An Organometallic Strategy for Cysteine Borylation
- Author
-
Mary A. Waddington, Alexander M. Spokoyny, Julia M. Stauber, Hayden R. Montgomery, Liban M. A. Saleh, Xin Zheng, Petr Král, and Elamar Hakim Moully
- Subjects
Boron Compounds ,chemistry.chemical_classification ,Bioconjugation ,Molecular Structure ,Chemistry ,Peptide ,General Chemistry ,010402 general chemistry ,01 natural sciences ,Biochemistry ,Combinatorial chemistry ,Borylation ,Article ,Catalysis ,0104 chemical sciences ,Residue (chemistry) ,Colloid and Surface Chemistry ,DARPin ,Organometallic Compounds ,Moiety ,Cysteine ,Chemoselectivity ,Platinum - Abstract
Synthetic bioconjugation at cysteine (Cys) residues in peptides and proteins has emerged as a powerful tool in chemistry. Soft nucleophilicity of the sulfur in Cys renders an exquisite chemoselectivity with which various functional groups can be placed onto this residue under benign conditions. While a variety of reactions have been successful at producing Cys-based bioconjugates, the majority of these feature sulfur-carbon bonds. We report Cys-borylation, wherein a benchtop stable Pt(II)-based organometallic reagent can be used to transfer a boron-rich cluster onto a sulfur moiety in unprotected peptides forging a boron-sulfur bond. Cys-borylation proceeds at room temperature and tolerates a variety of functional groups present in complex polypeptides. Further, the bioconjugation strategy can be applied to a model protein modification of Cys-containing DARPin (designed ankyrin repeat protein). The resultant bioconjugates show no additional toxicity compared to their Cys alkyl-based congeners. Finally, we demonstrate how the developed Cys-borylation can enhance the proteolytic stability of the resultant peptide bioconjugates while maintaining the binding affinity to a protein target.
- Published
- 2021